Ocera Therapeutics fka OCRX

[LongRun8]

I'm not 100% sure, but I think it's a combination of a few things:

1. It's almost like an IPO at this point; so there might be some excitement surrounding this previously private company with a new drug pipeline.
2. The float is very low.
3. A lot of people's shares are locked up until they are cleared back into their brokerage accounts due to the merger, name change, and ticker change. So maybe there is some manipulating of the price until the rest of the shares get unlocked, whether it's manipulation by the insiders who own the shares or by MMs. Otherwise, I guess it could truly be the public who is interested in this newly-made public company.

JMO.